We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NanoAssemblr™ Chosen for Horizon 2020 Project to Develop Novel RNA therapeutics

Product News   Mar 29, 2017 | Original story from Precision Nanosystems

 
NanoAssemblr™ Chosen for Horizon 2020 Project to Develop Novel RNA therapeutics

Credit: Precision NanoSystems

FURTHER INFORMATION
 
 
 

Related Product News

Nanoform and AstraZeneca Initiate Technology Evaluation

Product News

Nanoform has announced the initiation of a technology evaluation of Nanoform’s Proprietary CESS(R) Technology across a range of AstraZeneca’s proprietary pharmaceutical products.

READ MORE

Product and Personnel Protection With New Biological Safety Cabinet

Product News

Thermo Fisher Scientific has announced the Class II biological safety cabinet (BSC).

READ MORE

Advancing Small Scale GMP Production

Product News

AstraZeneca have invested in a LyoConstellationTM S10 freeze dryer, intended to help drive research and development of small scale GMP production.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE